These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25889091)

  • 1. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Wilinska ME; Hovorka R
    Biomed Eng Online; 2015 Mar; 14():19. PubMed ID: 25889091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Day-to-Day Variability of Glucose-Insulin Regulation Over 12-Week Home Use of Closed-Loop Insulin Delivery.
    Yue Ruan ; Wilinska ME; Thabit H; Hovorka R
    IEEE Trans Biomed Eng; 2017 Jun; 64(6):1412-1419. PubMed ID: 28113240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.
    Kanderian SS; Weinzimer S; Voskanyan G; Steil GM
    J Diabetes Sci Technol; 2009 Sep; 3(5):1047-57. PubMed ID: 20144418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Bally L; Gubler P; Thabit H; Hartnell S; Ruan Y; Wilinska ME; Evans ML; Semmo M; Vogt B; Coll AP; Stettler C; Hovorka R
    Kidney Int; 2019 Sep; 96(3):593-596. PubMed ID: 31133457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study.
    Reiterer F; Reiter M; Del Re L; Bechmann Christensen M; Nørgaard K
    J Diabetes Sci Technol; 2018 Sep; 12(5):1029-1040. PubMed ID: 29681172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    Alkhateeb H; El Fathi A; Ghanbari M; Haidar A
    PLoS One; 2021; 16(3):e0248280. PubMed ID: 33770092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.
    Underland LJ; Ilkowitz JT; Katikaneni R; Dowd A; Heptulla RA
    J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive and Personalized Plasma Insulin Concentration Estimation for Artificial Pancreas Systems.
    Hajizadeh I; Rashid M; Samadi S; Feng J; Sevil M; Hobbs N; Lazaro C; Maloney Z; Brandt R; Yu X; Turksoy K; Littlejohn E; Cengiz E; Cinar A
    J Diabetes Sci Technol; 2018 May; 12(3):639-649. PubMed ID: 29566547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study.
    Stull MC; Strilka RJ; Clemens MS; Armen SB
    J Diabetes Sci Technol; 2015 Jun; 10(1):137-44. PubMed ID: 26134836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy options for pediatric diabetes.
    Marcovecchio ML; Chiarelli F
    Curr Opin Pediatr; 2017 Aug; 29(4):481-487. PubMed ID: 28509784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
    Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
    Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
    Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
    Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.
    Haidar A; Farid D; St-Yves A; Messier V; Chen V; Xing D; Brazeau AS; Duval C; Boulet B; Legault L; Rabasa-Lhoret R
    Diabetes Metab; 2014 Jun; 40(3):211-4. PubMed ID: 24656963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.